Global Nicotinamide Riboside (NR) Market Report, History and Forecast 2018-2029

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Nicotinamide Riboside (NR) was estimated at US$ 21.46 million in the year 2022, is projected to reach a revised size of US$ 38.76 million by 2029, growing at a CAGR of 8.32 % during the forecast period 2023-2029.
North American market for Nicotinamide Riboside (NR) was valued at $ 9.78 million in 2022 and will reach $ 17.90 million by 2029, at a CAGR of 8.49 % during the forecast period of 2023 through 2029.
Asia-Pacific market for Nicotinamide Riboside (NR) was valued at $ 6.55 million in 2022 and will reach $ 12.26 million by 2029, at a CAGR of 9.08 % during the forecast period of 2023 through 2029.
Europe market for Nicotinamide Riboside (NR) was valued at $ 3.59 million in 2022 and will reach $ 6.26 million by 2029, at a CAGR of 7.35 % during the forecast period of 2023 through 2029.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nicotinamide Riboside (NR), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nicotinamide Riboside (NR).

The Nicotinamide Riboside (NR) market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Nicotinamide Riboside (NR) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicotinamide Riboside (NR) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

Market Segmentation

This report covers the Nicotinamide Riboside (NR) segments by manufacturers, by Type, by Application, by region and country, and provides market size (value, volume and average price) and CAGR for the history and forecast period (2018-2022, 2023-2029), considering 2022 as the base year. It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.

听

By Company听听 听

听听听听ChromaDex
听听听听Genex Formulas
听听听听Shandong Tianming Pharmaceutical
听听听听Bontac
听听听听Longer Livetech
听听听听Tiantai Biotechnology
听听听听EnzymeWorks
听听听听Suzhou MyLand Pharm & Nutrition
听听听听Shenzhen Ejion Biotechnology
听听听听Zhejiang Jiahua
听听听听Weitai Pharmaceutical

Segment by Type

听听听听Purity 鈮�98%
听听听听Purity 锛�98%

Segment by Application

听听听听Health Supplement
听听听听Pharmaceutical Additives

By Region
听听听听North America
听听听听U.S.
听听听听Canada

听听听听Asia-Pacific
听听听听China
听听听听Japan
听听听听Korea
听听听听India
听听听听Thailand

听听听听Europe
听听听听Germany
听听听听France
听听听听U.K.
听听听听Italy

听听听听Latin America
听听听听Mexico
听听听听Brazil
听听听听Argentina

听听听听Middle East & Africa
听听听听Middle East
听听听听Africa

听

Core Chapters

Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter Two: Detailed analysis of Nicotinamide Riboside (NR) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Nicotinamide Riboside (NR) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, Latin America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Nicotinamide Riboside (NR) Market Overview听听听1
1.1 Nicotinamide Riboside (NR) Product Overview听听听1
1.2 Nicotinamide Riboside (NR) Market by Type听听听3
1.3 Global Nicotinamide Riboside (NR) Market Size by Type听听听3
1.3.1 Global Nicotinamide Riboside (NR) Market Size Overview by Type (2018-2029)听听听4
1.3.2 Global Nicotinamide Riboside (NR) Historic Market Size Review by Type (2018-2023)听听听5
1.3.3 Global Nicotinamide Riboside (NR) Forecasted Market Size by Type (2024-2029)听听听6
1.4 Key Regions Market Size by Type听听听8
1.4.1 North America Nicotinamide Riboside (NR) Sales Breakdown by Type (2018-2023)听听听8
1.4.2 Europe Nicotinamide Riboside (NR) Sales Breakdown by Type (2018-2023)听听听9
1.4.3 Asia-Pacific Nicotinamide Riboside (NR) Sales Breakdown by Type (2018-2023)听听听11
1.4.4 Latin America Nicotinamide Riboside (NR) Sales Breakdown by Type (2018-2023)听听听13
1.4.5 Middle East and Africa Nicotinamide Riboside (NR) Sales Breakdown by Type (2018-2023)听听听15
2 Nicotinamide Riboside (NR) Market Competition by Company听听听18
2.1 Global Top Players by Nicotinamide Riboside (NR) Sales (2018-2023)听听听18
2.2 Global Top Players by Nicotinamide Riboside (NR) Revenue (2018-2023)听听听19
2.3 Global Top Players by Nicotinamide Riboside (NR) Price (2018-2023)听听听20
2.4 Global Top Manufacturers Nicotinamide Riboside (NR) Manufacturing Base Distribution, Sales Area听听听21
2.5 Nicotinamide Riboside (NR) Market Competitive Situation and Trends听听听22
2.5.1 Nicotinamide Riboside (NR) Market Concentration Rate (2018-2023)听听听22
2.5.2 Global 3 and 6 Largest Manufacturers by Nicotinamide Riboside (NR) Sales and Revenue in 2022听听听23
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nicotinamide Riboside (NR) as of 2022)听听听24
2.7 Date of Key Manufacturers Established听听听25
3 Nicotinamide Riboside (NR) Status and Outlook by Region听听听26
3.1 Global Nicotinamide Riboside (NR) Market Size and CAGR by Region: 2018 VS 2022 VS 2029听听听26
3.2 Global Nicotinamide Riboside (NR) Historic Market Size by Region听听听26
3.2.1 Global Nicotinamide Riboside (NR) Sales in Volume by Region (2018-2023)听听听26
3.2.2 Global Nicotinamide Riboside (NR) Sales in Value by Region (2018-2023)听听听27
3.2.3 Global Nicotinamide Riboside (NR) Sales (Volume & Value), Price and Gross Margin (2018-2023)听听听28
3.3 Global Nicotinamide Riboside (NR) Forecasted Market Size by Region听听听28
3.3.1 Global Nicotinamide Riboside (NR) Sales in Volume by Region (2024-2029)听听听28
3.3.2 Global Nicotinamide Riboside (NR) Sales in Value by Region (2024-2029)听听听29
3.3.3 Global Nicotinamide Riboside (NR) Sales (Volume & Value), Price and Gross Margin (2024-2029)听听听29
4 Nicotinamide Riboside (NR) by Application听听听31
4.1 Nicotinamide Riboside (NR) Market by Application听听听31
4.1.1 Health Supplement听听听31
4.1.2 Pharmaceutical Additives听听听32
4.2 Global Nicotinamide Riboside (NR) Market Size by Application听听听33
4.2.1 Global Nicotinamide Riboside (NR) Market Size Overview by Application (2018-2029)听听听34
4.2.2 Global Nicotinamide Riboside (NR) Historic Market Size Review by Application (2018-2023)听听听35
4.2.3 Global Nicotinamide Riboside (NR) Forecasted Market Size by Application (2024-2029)听听听36
4.3 Key Regions Market Size by Application听听听38
4.3.1 North America Nicotinamide Riboside (NR) Sales Breakdown by Application (2018-2023)听听听38
4.3.2 Europe Nicotinamide Riboside (NR) Sales Breakdown by Application (2018-2023)听听听39
4.3.3 Asia-Pacific Nicotinamide Riboside (NR) Sales Breakdown by Application (2018-2023)听听听41
4.3.4 Latin America Nicotinamide Riboside (NR) Sales Breakdown by Application (2018-2023)听听听43
4.3.5 Middle East and Africa Nicotinamide Riboside (NR) Sales Breakdown by Application (2018-2023)听听听45
5 North America Nicotinamide Riboside (NR) by Country听听听48
5.1 North America Nicotinamide Riboside (NR) Historic Market Size by Country听听听48
5.1.1 North America Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029听听听48
5.1.2 North America Nicotinamide Riboside (NR) Sales in Volume by Country (2018-2023)听听听48
5.1.3 North America Nicotinamide Riboside (NR) Sales in Value by Country (2018-2023)听听听49
5.2 North America Nicotinamide Riboside (NR) Forecasted Market Size by Country听听听49
5.2.1 North America Nicotinamide Riboside (NR) Sales in Volume by Country (2024-2029)听听听49
5.2.2 North America Nicotinamide Riboside (NR) Sales in Value by Country (2024-2029)听听听50
6 Europe Nicotinamide Riboside (NR) by Country听听听51
6.1 Europe Nicotinamide Riboside (NR) Historic Market Size by Country听听听51
6.1.1 Europe Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029听听听51
6.1.2 Europe Nicotinamide Riboside (NR) Sales in Volume by Country (2018-2023)听听听51
6.1.3 Europe Nicotinamide Riboside (NR) Sales in Value by Country (2018-2023)听听听52
6.2 Europe Nicotinamide Riboside (NR) Forecasted Market Size by Country听听听53
6.2.1 Europe Nicotinamide Riboside (NR) Sales in Volume by Country (2024-2029)听听听53
6.2.2 Europe Nicotinamide Riboside (NR) Sales in Value by Country (2024-2029)听听听53
7 Asia-Pacific Nicotinamide Riboside (NR) by Region听听听55
7.1 Asia-Pacific Nicotinamide Riboside (NR) Historic Market Size by Region听听听55
7.1.1 Asia-Pacific Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029听听听55
7.1.2 Asia-Pacific Nicotinamide Riboside (NR) Sales in Volume by Region (2018-2023)听听听55
7.1.3 Asia-Pacific Nicotinamide Riboside (NR) Sales in Value by Region (2018-2023)听听听56
7.2 Asia-Pacific Nicotinamide Riboside (NR) Forecasted Market Size by Region听听听57
7.2.1 Asia-Pacific Nicotinamide Riboside (NR) Sales in Volume by Region (2024-2029)听听听57
7.2.2 Asia-Pacific Nicotinamide Riboside (NR) Sales in Value by Region (2024-2029)听听听57
8 Latin America Nicotinamide Riboside (NR) by Country听听听59
8.1 Latin America Nicotinamide Riboside (NR) Historic Market Size by Country听听听59
8.1.1 Latin America Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029听听听59
8.1.2 Latin America Nicotinamide Riboside (NR) Sales in Volume by Country (2018-2023)听听听59
8.1.3 Latin America Nicotinamide Riboside (NR) Sales in Value by Country (2018-2023)听听听60
8.2 Latin America Nicotinamide Riboside (NR) Forecasted Market Size by Country听听听60
8.2.1 Latin America Nicotinamide Riboside (NR) Sales in Volume by Country (2024-2029)听听听60
8.2.2 Latin America Nicotinamide Riboside (NR) Sales in Value by Country (2024-2029)听听听61
9 Middle East and Africa Nicotinamide Riboside (NR) by Country听听听62
9.1 Middle East and Africa Nicotinamide Riboside (NR) Historic Market Size by Country听听听62
9.1.1 Middle East and Africa Nicotinamide Riboside (NR) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029听听听62
9.1.2 Middle East and Africa Nicotinamide Riboside (NR) Sales in Volume by Country (2018-2023)听听听62
9.1.3 Middle East and Africa Nicotinamide Riboside (NR) Sales in Value by Country (2018-2023)听听听63
9.2 Middle East and Africa Nicotinamide Riboside (NR) Forecasted Market Size by Country听听听63
9.2.1 Middle East and Africa Nicotinamide Riboside (NR) Sales in Volume by Country (2024-2029)听听听63
9.2.2 Middle East and Africa Nicotinamide Riboside (NR) Sales in Value by Country (2024-2029)听听听64
10 Company Profiles听听听65
10.1 ChromaDex听听听65
10.1.1 ChromaDex Company Information听听听65
10.1.2 ChromaDex Introduction and Business Overview听听听65
10.1.3 ChromaDex Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023)听听听66
10.1.4 ChromaDex Nicotinamide Riboside (NR) Products Offered听听听67
10.1.5 ChromaDex Recent Development听听听67
10.2 Genex Formulas听听听68
10.2.1 Genex Formulas Company Information听听听69
10.2.2 Genex Formulas Introduction and Business Overview听听听69
10.2.3 Genex Formulas Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023)听听听69
10.2.4 Genex Formulas Nicotinamide Riboside (NR) Products Offered听听听70
10.3 Shandong Tianming Pharmaceutical听听听71
10.3.1 Shandong Tianming Pharmaceutical Company Information听听听71
10.3.2 Shandong Tianming Pharmaceutical Introduction and Business Overview听听听71
10.3.3 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023)听听听72
10.3.4 Shandong Tianming Pharmaceutical Nicotinamide Riboside (NR) Products Offered听听听73
10.4 Bontac听听听73
10.4.1 Bontac Company Information听听听73
10.4.2 Bontac Introduction and Business Overview听听听74
10.4.3 Bontac Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023)听听听75
10.4.4 Bontac Nicotinamide Riboside (NR) Products Offered听听听75
10.5 Longer Livetech听听听75
10.5.1 Longer Livetech Company Information听听听76
10.5.2 Longer Livetech Introduction and Business Overview听听听76
10.5.3 Longer Livetech Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023)听听听77
10.5.4 Longer Livetech Nicotinamide Riboside (NR) Products Offered听听听77
10.6 Tiantai Biotechnology听听听77
10.6.1 Tiantai Biotechnology Company Information听听听78
10.6.2 Tiantai Biotechnology Introduction and Business Overview听听听78
10.6.3 Tiantai Biotechnology Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023)听听听79
10.6.4 Tiantai Biotechnology Nicotinamide Riboside (NR) Products Offered听听听79
10.7 EnzymeWorks听听听80
10.7.1 EnzymeWorks Company Information听听听80
10.7.2 EnzymeWorks Introduction and Business Overview听听听81
10.7.3 EnzymeWorks Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023)听听听81
10.7.4 EnzymeWorks Nicotinamide Riboside (NR) Products Offered听听听82
10.8 Suzhou MyLand Pharm & Nutrition听听听82
10.8.1 Suzhou MyLand Pharm & Nutrition Company Information听听听82
10.8.2 Suzhou MyLand Pharm & Nutrition Introduction and Business Overview听听听83
10.8.3 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023)听听听84
10.8.4 Suzhou MyLand Pharm & Nutrition Nicotinamide Riboside (NR) Products Offered听听听84
10.9 Shenzhen Ejion Biotechnology听听听85
10.9.1 Shenzhen Ejion Biotechnology Company Information听听听85
10.9.2 Shenzhen Ejion Biotechnology Introduction and Business Overview听听听85
10.9.3 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023)听听听86
10.9.4 Shenzhen Ejion Biotechnology Nicotinamide Riboside (NR) Products Offered听听听86
10.10 Zhejiang Jiahua听听听87
10.10.1 Zhejiang Jiahua Company Information听听听87
10.10.2 Zhejiang Jiahua Introduction and Business Overview听听听88
10.10.3 Zhejiang Jiahua Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023)听听听89
10.10.4 Zhejiang Jiahua Nicotinamide Riboside (NR) Products Offered听听听89
10.11 Weitai Pharmaceutical听听听89
10.11.1 Weitai Pharmaceutical Company Information听听听90
10.11.2 Weitai Pharmaceutical Introduction and Business Overview听听听90
10.11.3 Weitai Pharmaceutical Nicotinamide Riboside (NR) Sales, Revenue and Gross Margin (2018-2023)听听听91
10.11.4 Weitai Pharmaceutical Nicotinamide Riboside (NR) Products Offered听听听91
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis听听听93
11.1 Nicotinamide Riboside (NR) Key Raw Materials听听听93
11.1.1 Key Raw Materials听听听93
11.1.2 Key Raw Materials Price听听听93
11.1.3 Raw Materials Key Suppliers听听听94
11.2 Manufacturing Cost Structure听听听94
11.2.1 Raw Materials听听听95
11.2.2 Labor Cost听听听95
11.2.3 Manufacturing Expenses听听听95
11.3 Nicotinamide Riboside (NR) Industrial Chain Analysis听听听95
11.4 Nicotinamide Riboside (NR) Market Dynamics听听听96
11.4.1 Nicotinamide Riboside (NR) Industry Trends听听听96
11.4.2 Nicotinamide Riboside (NR) Market Drivers听听听96
11.4.3 Nicotinamide Riboside (NR) Market Challenges听听听97
11.4.4 Nicotinamide Riboside (NR) Market Restraints听听听97
12 Marketing Strategy Analysis, Distributors听听听98
12.1 Sales Channel听听听98
12.2 Nicotinamide Riboside (NR) Distributors听听听99
12.3 Nicotinamide Riboside (NR) Downstream Customers听听听100
13 Research Findings and Conclusion听听听101
14 Appendix听听听102
14.1 Research Methodology听听听102
14.1.1 Methodology/Research Approach听听听102
14.1.2 Data Source听听听105
14.2 Author Details听听听108
14.3 Disclaimer听听听110

Companies Mentioned:

听听听听ChromaDex
听听听听Genex Formulas
听听听听Shandong Tianming Pharmaceutical
听听听听Bontac
听听听听Longer Livetech
听听听听Tiantai Biotechnology
听听听听EnzymeWorks
听听听听Suzhou MyLand Pharm & Nutrition
听听听听Shenzhen Ejion Biotechnology
听听听听Zhejiang Jiahua
听听听听Weitai Pharmaceutical

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂